UGT1A10 activators are a class of compounds that enhance the activity or expression of the UGT1A10 enzyme, a member of the UDP-glucuronosyltransferase family involved in the metabolism of xenobiotics and endogenous substances through glucuronidation. These chemical activators can either directly interact with the UGT1A10 enzyme, leading to an increase in its catalytic activity, or they can act indirectly by upregulating the expression of the UGT1A10 gene. The mechanism of indirect activation usually involves the interaction with cellular receptors and transcription factors such as CAR, AhR, Nrf2, PPARs, and the glucocorticoid receptor. Compounds like Phenobarbital and Chrysin exert their activating effect by binding to these receptors and stimulating the transcriptional activity of genes encoding UGTs. The activation of these pathways results in an elevated expression of UGT1A10, thereby increasing the capacity for glucuronidation.
The diversity of structures within this chemical class is broad, encompassing natural compounds, synthetic drugs, and endogenous hormones. They may also impact UGT1A10 activity through stabilization of the enzyme's structure or by influencing the cellular environment that affects the enzyme's function. Activation of UGT1A10 is complex, involving multiple cellular processes and signaling pathways that govern gene expression, enzyme stability, and overall activity. Compounds that increase the bioavailability of cofactors or substrates required for the enzymatic action of UGT1A10 may also be considered as activators. This chemical class is instrumental for studying the metabolic pathways mediated by UGT1A10 and for understanding the regulation of this enzyme in physiological contexts. Their role in enhancing UGT1A10 activity provides insights into the intricate regulation of detoxification pathways and how various compounds can modulate these processes at a biochemical level.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Oltipraz modulates phase II detoxifying enzymes, including UGTs, by activating Nrf2, a transcription factor that can increase the expression of UGT1A10. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Sulforaphane activates the Nrf2 signaling pathway, leading to the transcriptional activation of detoxification enzymes, including UGT1A10. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
Clofibrate can induce UGT1A10 activity by engaging peroxisome proliferator-activated receptors (PPARs), which may upregulate UGT expression. | ||||||
5-Aminosalicylic acid | 89-57-6 | sc-202890 | 5 g | $26.00 | 4 | |
5-Aminosalicylic acid has been reported to enhance UGT1A10 activity by modulating pathways that regulate the synthesis of UGT enzymes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
Dexamethasone, a glucocorticoid, can stimulate UGT1A10 expression through glucocorticoid receptor-mediated transcriptional activation. | ||||||
DHEA | 53-43-0 | sc-202573 | 10 g | $109.00 | 3 | |
Androstenolone (DHEA) can upregulate UGT1A10 by activating nuclear receptors, resulting in increased expression of the enzyme. | ||||||
Zerumbone | 471-05-6 | sc-364148 sc-364148A | 10 mg 50 mg | $110.00 $400.00 | ||
Zerumbone is known to activate Nrf2 signaling, which may lead to upregulation of UGT1A10 expression as part of the antioxidant response. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol can enhance UGT1A10 activity possibly through the activation of SIRT1 and AMPK pathways, which are associated with the regulation of metabolic enzymes. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $57.00 $93.00 $240.00 $713.00 | 8 | |
Ellagic acid can influence the activity of UGT1A10 by modulating nuclear receptors and transcription factors that control the expression of UGT genes. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid may increase UGT1A10 expression by influencing retinoic acid receptors and their target genes in the metabolism of xenobiotics. | ||||||